血红蛋白病中的高凝状态:解读血栓威胁
β-地中海贫血和镰状细胞病(SCD)以高凝状态为特征,可显著影响器官并发症和疾病严重程度。红细胞和幼红细胞在其血栓形成发病机制中持续发挥核心作用,游离血红素、炎症性血管病、脾切除术等因素进一步增加血栓风险复杂性。本文描述β-地中海贫血和SCD患者血栓形成的发病机制,识别血红蛋白病促凝特征的共同机制,并综述当前可用的血栓预防和临床管理。
要点
- β-地中海贫血和镰状细胞病以高凝状态为特征,可显著影响器官并发症和疾病严重程度。
- 红细胞和幼红细胞在β-地中海贫血和SCD血栓形成发病机制中持续发挥核心作用。
- 游离血红素、炎症性血管病、脾切除术等因素进一步增加血栓风险复杂性。
核心结论
- 理解驱动高凝状态的众多因素有助于医疗从业者增强预防和治疗策略,并为未来开发新疗法。
研究设计与样本
- 综述:描述β-地中海贫血和SCD患者血栓形成的发病机制,识别血红蛋白病促凝特征的共同机制,并综述当前可用的血栓预防和临床管理。
主要发现
- β-地中海贫血和SCD以高凝状态为特征,可显著影响器官并发症和疾病严重程度。
- 红细胞和幼红细胞在β-地中海贫血和SCD血栓形成发病机制中持续发挥核心作用。
- 游离血红素、炎症性血管病、脾切除术等因素进一步增加血栓风险复杂性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Beta (β)-thalassemia and sickle cell disease (SCD) are characterized by a hypercoagulable state, which can significantly influence organ complication and disease severity. While red blood cells (RBCs) and erythroblasts continue to play a central role in the pathogenesis of thrombosis in β-thalassemia and SCD, additional factors such as free heme, inflammatory vasculopathy, splenectomy, among other factors further contribute to the complexity of thrombotic risk. Thus, understanding the role of the numerous factors driving this hypercoagulable state will enable healthcare practitioners to enhance preventive and treatment strategies and develop novel therapies for the future. We herein describe the pathogenesis of thrombosis in patients with β-thalassemia and SCD. We also identify common mechanisms underlying the procoagulant profile of hemoglobinopathies translating into thrombotic events. Finally, we review the currently available prevention and clinical management of thrombosis in these patient populations.
引用
- Bou-Fakhredin R, Cappellini MD, Taher AT, et al. Hypercoagulability in hemoglobinopathies: Decoding the thrombotic threat. Am J Hematol. 2024. PMID: 39400943. doi:10.1002/ajh.27500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。